Rachel D. Crouch
Rachel D. Crouch publishes mostly in Molecular Biology, Pharmacology and Computational Theory and Mathematics, on topics such as Pharmacogenetics and Drug Metabolism, Computational Drug Discovery Methods and Metabolomics and Mass Spectrometry Studies.
- World rank
- #4,649,434 of 7,710,434 ranked researchers
- Rank in United States
- #1,227,669 of 1,627,098
- Works
- 21
- Citations
- 324
- Citations per work
- 15.4
What does Rachel D. Crouch research?
Rachel D. Crouch's work is mostly in Biochemistry, Genetics and Molecular Biology (29%), Pharmacology, Toxicology and Pharmaceutics (27%), Computer Science (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1258.8%
- Everything else626.9%
- Physical Sciences29.5%
- Computer Science29.5%
- Health Sciences14.8%
- Medicine14.8%
- 1Molecular Biology29% of their works
- 2Pharmacology24% of their works
- 3Computational Theory and Mathematics10% of their works
- 4Pathology and Forensic Medicine5% of their works
- 5Pharmaceutical Science3% of their works
- 6Cellular and Molecular Neuroscience3% of their works
Research topics
- Pharmacogenetics and Drug Metabolism
- Computational Drug Discovery Methods
- Metabolomics and Mass Spectrometry Studies
- Alcohol Consumption and Health Effects
- Neuroscience and Neuropharmacology Research
- Chemical Reactions and Isotopes
- Drug-Induced Hepatotoxicity and Protection
- Drug Transport and Resistance Mechanisms
Which keywords describe Rachel D. Crouch's research?
The keywords of their largest research topics: Pharmacokinetics, Cytochrome P450, Pharmacogenetics, Medicinal Chemistry, Molecular Docking, Virtual Screening, Biomarkers and Oxidative Stress.
- Synaptic Plasticity
- Multidrug Resistance
- Drug-Induced Liver Injury
- Deuterium
- Metabolomics
- Liver Disease
- Oxidative Stress
- Virtual Screening
- Medicinal Chemistry
- Cytochrome P450
- Pharmacokinetics
- Pharmacogenetics
- Molecular Docking
- Biomarkers
- Alcohol
- Mass Spectrometry
- ATP-dependent Transporters
- Drug Discovery
- Hepatotoxicity
- Neurotransmission
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Pharmacokinetics182 topics
- Cytochrome P450121 topic
- Pharmacogenetics121 topic
- Medicinal Chemistry82 topics
- Molecular Docking61 topic
- Virtual Screening61 topic
- Biomarkers52 topics
- Oxidative Stress52 topics
- Alcohol31 topic
- Liver Disease31 topic
- Mass Spectrometry31 topic
- Metabolomics31 topic
- ATP-dependent Transporters21 topic
- Deuterium21 topic
- Drug Discovery21 topic
- Drug-Induced Liver Injury21 topic
- Hepatotoxicity21 topic
- Multidrug Resistance21 topic
- Neurotransmission21 topic
- Synaptic Plasticity21 topic
Where does Rachel D. Crouch work?
Rachel D. Crouch's main affiliation in the publication record is Lipscomb University, United States.
How many publications and citations does Rachel D. Crouch have?
OpenAlex counts 21 works and 324 citations for Rachel D. Crouch, an h-index of 8, ranking #4,649,434 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rachel D. Crouch. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.